Just two years af­ter launch, neu­ro start­up Eliem goes hunt­ing for busi­ness al­ter­na­tives

Eliem Ther­a­peu­tics has un­der­gone a strate­gic re­view just two years af­ter launch­ing dur­ing the pan­dem­ic biotech boom.

Eliem said Thurs­day morn­ing it plans to ex­plore …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER